These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36282697)

  • 1. Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice.
    Mu W; Zhen A; Carrillo MA; Rezek V; Martin H; Lizarraga M; Kitchen S
    J Vis Exp; 2022 Oct; (188):. PubMed ID: 36282697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
    Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent administration of IFNα14 and cART in TKO-BLT mice enhances suppression of HIV-1 viremia but does not eliminate the latent reservoir.
    Sutter K; Lavender KJ; Messer RJ; Widera M; Williams K; Race B; Hasenkrug KJ; Dittmer U
    Sci Rep; 2019 Dec; 9(1):18089. PubMed ID: 31792317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Intactness of Persistent Viral Genomes in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Initiating Antiretroviral Therapy within One Year of Infection.
    Long S; Fennessey CM; Newman L; Reid C; O'Brien SP; Li Y; Del Prete GQ; Lifson JD; Gorelick RJ; Keele BF
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Active HIV-1 Infection in CD34
    Latinovic OS; Neal LM; Tagaya Y; Heredia A; Medina-Moreno S; Zapata JC; Reitz M; Bryant J; Redfield RR
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):718-728. PubMed ID: 31099257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques.
    Ziani W; Bauer A; Lu H; Wang X; Wu X; Bar KJ; Li H; Liu D; Shaw GM; Veazey RS; Xu H
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33568508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific Activation
    Li G; Zhang Z; Reszka-Blanco N; Li F; Chi L; Ma J; Jeffrey J; Cheng L; Su L
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30971469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a Novel Humanized Mouse Model To Investigate
    Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring HIV DNA and cellular activation markers in HIV-infected humanized mice under cART.
    Rochat MA; Schlaepfer E; Kuster SP; Li D; Audige A; Ivic S; Fahrny A; Speck RF
    Virol J; 2018 Dec; 15(1):191. PubMed ID: 30558630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy.
    Martínez-Bonet M; Puertas MC; Fortuny C; Ouchi D; Mellado MJ; Rojo P; Noguera-Julian A; Muñoz-Fernández MA; Martinez-Picado J
    Clin Infect Dis; 2015 Oct; 61(7):1169-78. PubMed ID: 26063721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research.
    Bauer AM; Ziani W; Lindemuth E; Kuri-Cervantes L; Li H; Lee FH; Watkins M; Ding W; Xu H; Veazey R; Bar KJ
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.
    Dashti A; Waller C; Mavigner M; Schoof N; Bar KJ; Shaw GM; Vanderford TH; Liang S; Lifson JD; Dunham RM; Ferrari G; Tuyishime M; Lam CK; Nordstrom JL; Margolis DM; Silvestri G; Chahroudi A
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection dynamics and viral rebound: Modeling results from humanized mice.
    Guo T; Deng Q; Qiu Z; Rong L
    J Theor Biol; 2023 Jun; 567():111490. PubMed ID: 37054969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
    Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese rhesus macaques.
    Ling B; Piatak M; Rogers L; Johnson AM; Russell-Lodrigue K; Hazuda DJ; Lifson JD; Veazey RS
    PLoS One; 2014; 9(7):e102795. PubMed ID: 25033210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
    Aamer HA; McClure J; Ko D; Maenza J; Collier AC; Coombs RW; Mullins JI; Frenkel LM
    PLoS Pathog; 2020 Aug; 16(8):e1008791. PubMed ID: 32841299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques.
    McBrien JB; Wong AKH; White E; Carnathan DG; Lee JH; Safrit JT; Vanderford TH; Paiardini M; Chahroudi A; Silvestri G
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques.
    Abreu CM; Veenhuis RT; Avalos CR; Graham S; Parrilla DR; Ferreira EA; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Mac Gabhann F; O'Connor SL; Gama L; Clements JE
    mBio; 2019 Aug; 10(4):. PubMed ID: 31431552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4
    Obregon-Perko V; Bricker KM; Mensah G; Uddin F; Kumar MR; Fray EJ; Siliciano RF; Schoof N; Horner A; Mavigner M; Liang S; Vanderford T; Sass J; Chan C; Berendam SJ; Bar KJ; Shaw GM; Silvestri G; Fouda GG; Permar SR; Chahroudi A
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33087463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model.
    Goswami R; Nelson AN; Tu JJ; Dennis M; Feng L; Kumar A; Mangold J; Mangan RJ; Mattingly C; Curtis AD; Obregon-Perko V; Mavigner M; Pollara J; Shaw GM; Bar KJ; Chahroudi A; De Paris K; Chan C; Van Rompay KKA; Permar SR
    mBio; 2019 Sep; 10(5):. PubMed ID: 31488511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.